Litcius/Paper detail

Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome

Philipp Klemm, Ulf Müller‐Ladner, Ingo H. Tarner, Uwe Lange, Ole Hudowenz

2020Autoimmunity Reviews15 citationsDOI

Topics & Concepts

AutoimmunityImmunologyAntiphospholipid syndromeImmune systemAutoantibodyAntibodyB cellImmune tolerancePeripheral toleranceB-cell activating factorMedicineBiologySystemic Lupus Erythematosus ResearchDiabetes and associated disordersLiver Diseases and Immunity
Belimumab reduces antiphospholipid antibodies in primary triple-positive antiphospholipid syndrome | Litcius